References
- Gibaldi M., Perrier D. Pharmacokinetics. Marcel Dekker, Inc., NY 1982
- Gitlin G., Bayer E. A., Wilchek M. Studies on the biotin-binding sites of avidin and streptavidin. Biochem. J. (1990); 269: 527–530
- Green N. M. Avidin and streptavidin. Methods Enzymol. (1990); 184: 51–67
- Hiller Y., Gershoni J. M., Bayer E. A., Wilchek M. Biotin binding to avidin. Biochem. J. (1987); 248: 167–171
- Kang Y.-S., Pardridge W. M. Use of neutral-avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate. J. Pharmacol. Exp. Ther. (1994a); 269: 344–350
- Kang Y.-S., Pardridge W. M. Brain delivery of biotin bound to a conjugate of neutral avidin and cationized human albumin. Pharm. Res. (1994b); 11: 1257–1264
- Klibanov A. L., Martynov A. V., Slinkin M. A., Sakharov I. Y., Smirnov M. D., Muzykantov V. R., Danilov S. M., Torchilin V. P. Blood clearance of radiolabeled antibody: enhancement of lactosamination and treatment with biotin-avidin or anti-mouse IgG antibodies. J. Nucl. Med. (1988); 29: 1951–1956
- Oldendorf W. H., Hyman S., Braun L., Oldendorf S. Z. Blood-brain barrier: penetration of morphine, codeine, heroin, and methadone after carotid injection. Science (1972); 178: 984
- Pardridge W. M. Peptide Drug Delivery to the Brain. Raven Press, NY (1991); 1–357
- Pardridge W. M., Boado R. J. Enhanced cellular uptake of biotinylated antisense oligonucleotide or peptide mediated by avidin, a cationic protein. FEES Lett. (1991); 288: 30–32
- Pardridge W. M., Boado R. J., Buciak J. L. Drug delivery of antisense oligonucleotides or peptides to tissues in vivo using an avidin-biotin system. Drug Delivery (1993); 1: 43–50
- Pardridge W. M., Buciak J. L., Yoshikawa T. Transport of recombinant CD4 through the rat blood-brain barrier. J. Pharmacol. Exp. Ther. (1992); 261: 1175–1180
- Schechter B., Silberman R., Arnon R., Wilchek M. Tissue distribution of avidin and streptavidin injected to mice. Eur. J. Biochem. (1990); 189: 327–331
- Shi F., Bailey C., Malick A. W., Audus K. L. Biotin uptake and transport across bovine brain microvessel endothelial cell monolayers. Pharm. Res. (1993); 10: 282–288
- Sinitsyn V. V., Mamontova A. G., Checkneva Y. Y., Shnyra A. A., Domogatsky S. P. Rapid blood clearance of biotinylated IgG after infusion of avidin. J. Nucl. Med. (1989); 30: 66–69
- Smith Q. R., Ziylan Y. Z., Robinson P. J., Rapoport S. I. Kinetics and distribution volumes for tracers of different sizes in the brain plasma space. Brain Res. (1988); 462: 1–9
- Spector R., Mock D. Biotin transport through the blood-brain barrier. J. Neurochem. (1987); 48: 400–404
- Wei R. D., Kou D. H., Hoo S. L. Dissociation of avidin-biotin complex in vivo. Experientia (1970); 27: 366–368
- Wilchek M., Bayer E. A. Avidin-biotin immobilisation systems. Immobilised Macromolecules: Application Potentials, U. B. Sletyr, P. Messner, D. Pum, M. Sara. Springer-Verlag, NY (1993); 51–60
- Yamasaki R. B., Vega A., Feeney R. E. Modification of available arginine residues in proteins by p-hydroxyphenylglyoxal. Anal. Biochem. (1980); 109: 32–40
- Yoshikawa T., Pardridge W. M. Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor. J. Pharmacol. Exp. Ther. (1992); 263: 897–903